Skip to the main content
The Crier

NKp46+CD3+ cells as a Novel Target for Vaccines Against Bovine TB

Your saved contracts

What the buyer wrote

The Morrison and Vordermeier laboratories have recently identified a novel NKp46+CD3+ non-conventional T-cell population in cattle and demonstrated that a subset of these cells recognise phosphatidylinositol mannosides (PIMs - a group of membrane bound lipids) from Mb. In this project we propose to i) examine NKp46+CD3+ T-cell responses during a BCG-immunisation/Mb-challenge study so as to gain some insights into the role of lipid-specific T-cells in bTB and ii) explore the breadth of lipids from TB that act as antigens for bovine T-cells and evaluate their potential as vaccine antigens. Specifically we aim to address the following questions: 1. What are the quantitative and kinetic ch…

Read all of it on Contracts Finder →

Bid for this and lost? There is a short window in which the decision can be questioned.

Awarded to

APHA£258.5kends (3 Mar 2019)

Details

What the buyer calls it
NKp46+CD3+ cells as a Novel Target for Vaccines Against Bovine TB
How they are buying
The buyer did not say
Type
services
Suitable for small firms
The buyer says yes. What that is worth
Work starts
31 Mar 2016
Work ends
3 Mar 2019

Who the buyer named

Emma Roberts was the named contact on this notice.

emisk@cefas.co.uk